A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trial

the IXORA-R Study Group

科研成果: 期刊稿件文章同行评审

111 引用 (Scopus)
源语言英语
页(从-至)1348-1358
页数11
期刊British Journal of Dermatology
182
6
DOI
出版状态已出版 - 6月 1 2020

!!!ASJC Scopus Subject Areas

  • 皮肤医学

指纹

探究 'A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trial' 的科研主题。它们共同构成独一无二的指纹。

引用此